Jean‐Jacques Kiladjian
Délégation Paris 5(FR)Centre National de la Recherche Scientifique(FR)Inserm(FR)Inserm(FR)Université Paris Cité(FR)Saint Louis University Hospital(US)Sorbonne Paris Cité(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)Paris Cardiovascular Research Center(FR)Hôpital Saint-Louis(FR)King's College Hospital(GB)Institut de recherche Saint-Louis(FR)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Eosinophilic Disorders and Syndromes, Kruppel-like factors research
Most-Cited Works
- → International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data(2022)2,479 cited
- → Baveno VII – Renewing consensus in portal hypertension(2021)2,459 cited
- → JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis(2012)1,766 cited
- → Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin(2002)1,232 cited
- → Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera(2015)858 cited
- → Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet(2011)826 cited